23 Feb Kriya Therapeutics
Posted at 19:23h
in
Curt Herberts, President and Chief Operating Officer
Oct. 9 | 11:30pm | FLW Ballroom G
Palo Alto, CA
(Private)
Kriya is a biopharmaceutical company developing gene therapies to address common diseases affecting millions of people around the world. The company’s pipeline includes gene therapies for diseases such as diabetes, NASH, geographic atrophy, thyroid eye disease, epilepsy, and trigeminal neuralgia. Kriya’s platform integrates cutting edge infrastructure and technology across translational research, computational biology, and scalable manufacturing to accelerate the timeline and drive down the cost of designing, developing, and manufacturing transformational gene therapies.
